Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Munira Essat, Paul Tappenden, Shijie Ren, Alice Bessey, Rachel Archer, Ruth Wong, Alan Lobo, Sami Hoque
  • PharmacoEconomics, October 2015, Springer Science + Business Media
  • DOI: 10.1007/s40273-015-0334-3
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Munira Essat